E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33%
Market Cap: 92.2B EUR

Wall Street
Price Targets

EPE Price Targets Summary
Epizyme Inc

There are no price targets for EPE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Epizyme Inc Competitors:
Price Targets
AMRN
Amarin Corporation PLC
9% Downside
AZT
Arcticzymes Technologies ASA
63% Upside
GILD
Gilead Sciences Inc
10% Upside
FOLD
Amicus Therapeutics Inc
14% Upside
IVA
Inventiva SA
212% Upside
9966
Alphamab Oncology
7% Upside
BMRN
Biomarin Pharmaceutical Inc
56% Upside
MRUS
Merus NV
11% Upside

Revenue
Forecast

Revenue Estimate
Epizyme Inc

For the last 8 years the compound annual growth rate for Epizyme Inc's revenue is -7%. The projected CAGR for the next 1 year is 102%.

-7%
Past Growth
102%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Epizyme Inc

Operating Income forecast
is not available for
Epizyme Inc

Net Income
Forecast

Net Income Estimate
Epizyme Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EPE's stock price target?
Not Available

EPE doesn't have any price targets made by Wall Street professionals.

What is Epizyme Inc's Revenue forecast?
Projected CAGR
102%

For the last 8 years the compound annual growth rate for Epizyme Inc's revenue is -7%. The projected CAGR for the next 1 year is 102%.

Back to Top